Close
Nordic 9Nordic 9

Sixty Degree Capital (investor - Private Equity)

Canada
See something wrong or missing? Let us know
Offices:Toronto
Average round investment:91.14M USD
Average number per year:3.0
Distribution: 2025 (3)
Portfolio companies: Italy AAVantgarde BioGermany DroidrunSwitzerland GlycoEra
Mostly invests in: Italy Italy (1) Biotech (2)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Sixty Degree Capital

Name Criteria
Hong Kong Horizons Ventures
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Mobile, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, Switzerland
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
United Kingdom IAG Silverstripe
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Mobile, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Netherlands Gilde Healthcare
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services, AI (big data), Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, Switzerland
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
United States Sapphire Ventures
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Mobile, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
United Kingdom Advent Life Sciences
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services, AI (big data), Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: Switzerland
  • Average number of deals per year: 3.4
  • Active last 12 months: Yes
Germany Athos Service
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services, AI (big data), Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, Switzerland
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Israel Canaan Partners
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services, AI (big data), Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, Switzerland
  • Average number of deals per year: 3.7
  • Active last 12 months: Yes
United States Benchmark
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Mobile, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Italy, Germany
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Denmark AP Møller Holding
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany, Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Addition
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Mobile, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Italy, Germany, Switzerland
  • Average number of deals per year: 4.2
  • Active last 12 months: Yes
Top